PGY Q1 2026 Earnings EPS Surges 263 Above Estimates Amid Strong Performance Lyell Immunopharma Q1 2026 Earnings Narrower Loss Surprises Expectations Amid Clinical Progress IMPPP Q1 2026 Earnings Strong EPS Surprise of 644 Exceeds Expectations FRAF Q1 2026 Earnings EPS Beats Estimates Stock Declines SRRK Q1 2026 Earnings Narrowed EPS Miss and Steady Pipeline Progress Amid No Revenue NFE Q1 2026 Earnings EPS Misses Estimates as Losses Widen